Vitamin c boost for cancer treatment? early trial tests immune Power-Up
NCT ID NCT06083454
Summary
This early-stage study aimed to see if adding high-dose vitamin C (ascorbate) to an immunotherapy drug (durvalumab) before surgery could help the body's immune system fight early-stage lung cancer. It compared three approaches: the drug alone, the drug plus vitamin C, or just surgery. The main goal was to measure changes in immune cells in the tumor after this pre-surgery treatment. The study was terminated early after enrolling only one person.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Iowa
Iowa City, Iowa, 52242, United States
Conditions
Explore the condition pages connected to this study.